23 Participants Needed

Weight Loss Surgery for Fatty Liver Disease

C
Overseen ByCoordinator
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Washington University School of Medicine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial is studying if losing a lot of weight can help reduce liver scarring in people with obesity who have a common liver disease called NAFLD. The goal is to see if weight loss can prevent severe liver problems.

Eligibility Criteria

This trial is for individuals with obesity, specifically those who have a body mass index (BMI) of 35 kg/m2 or higher and are scheduled for weight loss surgery. It's not open to pregnant individuals, people with liver diseases other than NAFLD, those who've had bariatric surgery before, anyone with significant organ dysfunction/disease, tobacco users, or heavy alcohol drinkers.

Exclusion Criteria

Pregnancy
Excessive alcohol use
Tobacco use
See 3 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

Pre-surgery Assessment

Participants undergo various assessments including genotyping, body composition, and insulin sensitivity before weight loss surgery

Up to 6 months

Weight Loss Surgery

Participants undergo weight loss surgery to achieve significant weight loss

1 visit (in-person)

Post-surgery Follow-up

Participants are monitored for changes in liver fibrogenesis, lipid turnover, and other metabolic functions after weight loss

Up to 6 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Weight loss surgery
Trial Overview The study is looking at how effective significant weight loss from bariatric surgery can be on improving liver health in people with non-alcoholic fatty liver disease (NAFLD). The focus is on the rate of hepatic fibrogenesis reduction post-surgery.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Weight lossExperimental Treatment1 Intervention
Participants will undergo weight loss surgery

Find a Clinic Near You

Who Is Running the Clinical Trial?

Washington University School of Medicine

Lead Sponsor

Trials
2,027
Recruited
2,353,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security